The effects that a pause may have on your body may depend on why you're taking the medication in the first place.

Around the holidays, when many people are baking cookies for Santa, enjoying cocktail parties or having festive family feasts ...

Ozempic's meteoric rise has reshaped the landscape of healthcare, retail, and consumer behavior. Its initial popularity as a weight loss ...

Novo Nordisk has an opportunity to expand indications on its weight loss drugs. Check out on what could be next for NVO stock ...

One lawmaker said the CT Department of Social Services told him the agency wasn’t paying for FDA-approved drugs because of ...

Discover the truth behind FitSpresso reviews—find out how this powerful weight loss supplement transformed my body in just 30 ...

( NewsNation) — The director of medical weight management at West Virginia University says a canceled pilot program that ...

Independence Blue Cross said starting Jan. 1 it will only be covering GLP-1 agonists — commonly sold under brand names like ...

Studies are limited, but health experts say imbibing on a GLP-1 drug can carry some theoretical risks. Here are 7 things to ...

The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...

Looking ahead to 2025 is a team of Evercore ISI strategists led by Julian Emanuel, who in our call of the day, offer up some stocks which lost ground in 2024 but which could be see a rebound in the ...

Novo Nordisk's shares recovered some ground on Monday after a 27% slump on Friday in response to an underwhelming set of results from a Phase III trial of its new weight-loss drug CagriSema, but ...